[
    [
        {
            "time": "",
            "original_text": "牛市初期医药股或持续高烧，疫苗短期有市梦率风险，但更多优质股3-5年成长逻辑未变",
            "features": {
                "keywords": [
                    "牛市",
                    "医药股",
                    "疫苗",
                    "市梦率",
                    "优质股",
                    "成长逻辑"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "牛市初期医药股或持续高烧，疫苗短期有市梦率风险，但更多优质股3-5年成长逻辑未变",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "生物制品Ⅱ：全球新冠疫苗积极进展 看好新冠疫苗商业化价值",
            "features": {
                "keywords": [
                    "生物制品",
                    "新冠疫苗",
                    "商业化价值"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物制品Ⅱ：全球新冠疫苗积极进展 看好新冠疫苗商业化价值",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "新冠疫苗连传好消息，还有“大肉签”要来，行业进入黄金发展期丨牛熊眼",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "好消息",
                    "大肉签",
                    "黄金发展期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠疫苗连传好消息，还有“大肉签”要来，行业进入黄金发展期丨牛熊眼",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[行情]疫苗板块再度冲高，万泰生物大涨7%，冠昊生物、智飞生物、鹏鹞环保、康泰生物等跟涨",
            "features": {
                "keywords": [
                    "疫苗板块",
                    "万泰生物",
                    "冠昊生物",
                    "智飞生物",
                    "鹏鹞环保",
                    "康泰生物"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[行情]疫苗板块再度冲高，万泰生物大涨7%，冠昊生物、智飞生物、鹏鹞环保、康泰生物等跟涨",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "新冠疫苗第一股：中一签或赚17万，明天打新",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "第一股",
                    "中一签",
                    "打新"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠疫苗第一股：中一签或赚17万，明天打新",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        }
    ]
]